Yoshiki Sekijima1, Masahide Yazaki2, Kazuhiro Oguchi2, Naoki Ezawa2, Tsuneaki Yoshinaga2, Mitsunori Yamada2, Hiroyuki Yahikozawa2, Masahide Watanabe2, Fuyuki Kametani2, Shu-Ichi Ikeda2. 1. From the Departments of Medicine (Neurology and Rheumatology) (Y.S., M.Y., N.E., T.Y., S.-i.I.) and Brain Disease Research (M.Y.), Shinshu University School of Medicine; Institute for Biomedical Sciences (Y.S., M.Y., S.-i.I.), Shinshu University; Jisenkai Brain Imaging Research Center (Y.S., K.O.); Departments of Neurology (H.Y.) and Pathology (M.W.), Nagano Red Cross Hospital; and Department of Dementia and Higher Brain Function (F.K.), Tokyo Metropolitan Institute of Medical Science, Japan. sekijima@shinshu-u.ac.jp. 2. From the Departments of Medicine (Neurology and Rheumatology) (Y.S., M.Y., N.E., T.Y., S.-i.I.) and Brain Disease Research (M.Y.), Shinshu University School of Medicine; Institute for Biomedical Sciences (Y.S., M.Y., S.-i.I.), Shinshu University; Jisenkai Brain Imaging Research Center (Y.S., K.O.); Departments of Neurology (H.Y.) and Pathology (M.W.), Nagano Red Cross Hospital; and Department of Dementia and Higher Brain Function (F.K.), Tokyo Metropolitan Institute of Medical Science, Japan.
Abstract
OBJECTIVE: To investigate the prevalence and clinical features of posttransplant CNS symptoms in patients with hereditary ATTR amyloidosis and their Pittsburgh compound B (PiB)-PET imaging correlates. METHODS: We monitored prevalence and type of CNS symptoms in 53 consecutive posttransplant patients with hereditary ATTR amyloidosis. (11)C-PiB-PET was performed in 15 patients with various disease durations. We also analyzed pathologic and biochemical characteristics of ATTR amyloid deposition in the brain of a posttransplant patient. RESULTS: Transient focal neurologic episodes (TFNEs) attributed to ATTR-type cerebral amyloid angiopathy (CAA) were found in 11.3% of posttransplant hereditary ATTR amyloidosis patients. TFNE occurred on average 16.8 years after onset of the disease. Patients with longer duration of illness (≥10 years) showed increased (11)C-PiB retention in the brain. The (11)C-PiB accumulation pattern in hereditary ATTR amyloidosis was unique and different from those in Alzheimer disease or Aβ-type CAA. In the autopsy case, ATTR amyloid deposition was mainly localized to leptomeningeal vessels and leptomeninges of the brain. Amyloid fibrils in the brain were almost completely composed of variant transthyretin (TTR). CONCLUSIONS: TFNE due to ATTR-type CAA occurred frequently in posttransplant patients with long disease durations. (11)C-PiB-PET is a useful diagnostic tool for ATTR-type CAA. ATTR amyloid deposition in the CNS, as measured by PiB-PET, was detected approximately 10 years before onset of TFNE.
OBJECTIVE: To investigate the prevalence and clinical features of posttransplant CNS symptoms in patients with hereditary ATTRamyloidosis and their Pittsburgh compound B (PiB)-PET imaging correlates. METHODS: We monitored prevalence and type of CNS symptoms in 53 consecutive posttransplant patients with hereditary ATTRamyloidosis. (11)C-PiB-PET was performed in 15 patients with various disease durations. We also analyzed pathologic and biochemical characteristics of ATTR amyloid deposition in the brain of a posttransplant patient. RESULTS: Transient focal neurologic episodes (TFNEs) attributed to ATTR-type cerebral amyloid angiopathy (CAA) were found in 11.3% of posttransplant hereditary ATTRamyloidosispatients. TFNE occurred on average 16.8 years after onset of the disease. Patients with longer duration of illness (≥10 years) showed increased (11)C-PiB retention in the brain. The (11)C-PiB accumulation pattern in hereditary ATTRamyloidosis was unique and different from those in Alzheimer disease or Aβ-type CAA. In the autopsy case, ATTR amyloid deposition was mainly localized to leptomeningeal vessels and leptomeninges of the brain. Amyloid fibrils in the brain were almost completely composed of variant transthyretin (TTR). CONCLUSIONS:TFNE due to ATTR-type CAA occurred frequently in posttransplant patients with long disease durations. (11)C-PiB-PET is a useful diagnostic tool for ATTR-type CAA. ATTR amyloid deposition in the CNS, as measured by PiB-PET, was detected approximately 10 years before onset of TFNE.
Authors: Riemer H J A Slart; Andor W J M Glaudemans; Walter Noordzij; Johan Bijzet; Bouke P C Hazenberg; Hans L A Nienhuis Journal: Eur J Nucl Med Mol Imaging Date: 2019-04-23 Impact factor: 9.236
Authors: Stephen Connelly; David E Mortenson; Sungwook Choi; Ian A Wilson; Evan T Powers; Jeffery W Kelly; Steven M Johnson Journal: Bioorg Med Chem Lett Date: 2017-05-26 Impact factor: 2.823
Authors: Xin Jiang; Richard Labaudinière; Joel N Buxbaum; Cecília Monteiro; Marta Novais; Teresa Coelho; Jeffery W Kelly Journal: Proc Natl Acad Sci U S A Date: 2021-03-02 Impact factor: 11.205
Authors: Cecilia Monteiro; Ana Martins da Silva; Natália Ferreira; Jaleh Mesgarzadeh; Marta Novais; Teresa Coelho; Jeffery W Kelly Journal: Amyloid Date: 2018-07-11 Impact factor: 7.141